are glp-1 receptor agonists approved for type 1 diabetes fda GLP-1/GIP and Diabetic Retinopathy: What ODs Should Know Exploration of the potential association
Description
doi: 10.1111/j.1463-1326.2012.01676.x
Do You Experience: water retention aches and pains all over from inflammation fatigue constant hunger or food talk high blood pressure high cholesterol nonalcoholic fatty liver obesity What Does This Look Like For You
While nasal administration has been explored as a strategy to bypass the bloodbrain barrier (BBB), the extent to which GLP-1 analogues benefit from this route depends heavily on their molecular characteristics
An oral preparation of semaglutide is also available
[176].Novo Nordisk A/S, Novo Nordisk Annual Report 2011, 2012
